Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
Endocrine therapies act by either blocking or downregulating the oestrogen receptor or by reducing oestrogen concentrations around and within the cancer cell. In postmenopausal women, oestrogen suppression is achieved by inhibition of the enzyme aromatase by aromatase inhibitors (AIs). Modern AIs (a...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2004
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064088/ |